Organigram (OGI) Competitors

Organigram (NASDAQ:OGI) and Prothena (NASDAQ:PRTA) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, profitability, community ranking, dividends and analyst recommendations.

Which has more volatility & risk, OGI or PRTA?

Organigram has a beta of 1.1, meaning that its stock price is 10% more volatile than the S&P 500. Comparatively, Prothena has a beta of 0.07, meaning that its stock price is 93% less volatile than the S&P 500.

Do analysts recommend OGI or PRTA?

Prothena has a consensus price target of $55.00, indicating a potential upside of 497.83%. Given Prothena's higher probable upside, analysts plainly believe Prothena is more favorable than Organigram.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Organigram	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Prothena	0 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.75

Is OGI or PRTA more profitable?

Organigram has a net margin of -31.69% compared to Prothena's net margin of -90.50%. Organigram's return on equity of -8.59% beat Prothena's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Organigram	-31.69%	-8.59%	-6.54%
Prothena	-90.50%	-22.67%	-19.68%

Does the MarketBeat Community prefer OGI or PRTA?

Prothena received 414 more outperform votes than Organigram when rated by MarketBeat users. However, 70.71% of users gave Organigram an outperform vote while only 70.43% of users gave Prothena an outperform vote.

Company	Underperform	Outperform
Organigram	Outperform Votes 198 70.71%	Underperform Votes 82 29.29%
Prothena	Outperform Votes 612 70.43%	Underperform Votes 257 29.57%

Which has better earnings & valuation, OGI or PRTA?

Organigram has higher revenue and earnings than Prothena. Prothena is trading at a lower price-to-earnings ratio than Organigram, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Organigram	$166.12M	0.88	-$33.39M	-$0.38	-3.05
Prothena	$135.16M	3.66	-$147.03M	-$2.30	-4.00

Do institutionals and insiders believe in OGI or PRTA?

34.6% of Organigram shares are held by institutional investors. Comparatively, 97.1% of Prothena shares are held by institutional investors. 0.1% of Organigram shares are held by company insiders. Comparatively, 9.2% of Prothena shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Does the media prefer OGI or PRTA?

In the previous week, Prothena had 3 more articles in the media than Organigram. MarketBeat recorded 5 mentions for Prothena and 2 mentions for Organigram. Organigram's average media sentiment score of 0.63 beat Prothena's score of 0.43 indicating that Organigram is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Organigram	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Prothena	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Organigram beats Prothena on 11 of the 18 factors compared between the two stocks.